EUVIMEDEUVIMED entdecken
Crossref

A CASE OF RHD-NEGATIVE OBSTETRIC CRITICAL HEMORRHAGE SUCCESSFULLY TREATED WITH MASSIVE RHD-POSITIVE BLOOD TRANSFUSION, FOLLOWED BY ANTI-D ANTIBODY PRODUCTION AND DELAYED HEMOLYTIC TRANSFUSION REACTION

Mio Kasabata, Ai Mochihara, Tamaka Miyamoto, Yoshihide Hokamuro, Natsuki Eguchi, Tomonori Hamada, Yukiko Tazaki, Hiroaki Kobayashi, Tatsuro Nakamura, Heiichiro Hamada, Yoshitaka Furukawa

Japanese Journal of Transfusion and Cell Therapy · 25.06.2026 · 72 (3) · 610-615

DOI: 10.3925/jjtc.72.610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Transfusion and Cell Therapy, erschienen am 25.06.2026. Verfasst von Mio Kasabata und 10 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guidelines for critical hemorrhage allow RhD-positive blood transfusion to an RhD-negative patient when the patient does not have anti-D antibody in life-threatening situations. However, reports of this practice in women of childbearing age are rare. We report an RhD-negative woman who suffered cardiac arrest due to amniotic fluid embolism after cesarean section. She was resuscitated with massive transfusion, which included RhD-positive blood [74 units of RBC (including 66 units of RhD-positive RBC), 84 units of FFP (including 80 units of RhD-positive FFP), 60 units of PC (all RhD-positive) ], warm fresh whole blood (27.5 units, all RhD-positive) and 18 g of fibrinogen concentrate. On day 26, anti-D antibody appeared, followed by delayed hemolytic transfusion reaction. The peak of DHTR was on day 31, after which the DHTR improved, and she was discharged on day 42. This case illustrates that RhD-positive blood transfusion can be lifesaving even in RhD-negative women of childbearing age under critical post-partum hemorrhage. However, it carries a risk of anti-D alloimmunization and DHTR, and post-resuscitation management should include antibody screening and monitoring of hemolysis markers. Further, in-hospital blood collection was a valuable supplementary resource in the face of a severe blood supply shortage.

Zitieren

APA

Kasabata, M., Mochihara, A., Miyamoto, T., Hokamuro, Y., Eguchi, N., Hamada, T., Tazaki, Y., Kobayashi, H., Nakamura, T., Hamada, H., & Furukawa, Y. (2026). A CASE OF RHD-NEGATIVE OBSTETRIC CRITICAL HEMORRHAGE SUCCESSFULLY TREATED WITH MASSIVE RHD-POSITIVE BLOOD TRANSFUSION, FOLLOWED BY ANTI-D ANTIBODY PRODUCTION AND DELAYED HEMOLYTIC TRANSFUSION REACTION. Japanese Journal of Transfusion and Cell Therapy, 72(3), 610-615. https://doi.org/10.3925/jjtc.72.610

Vancouver

Kasabata M, Mochihara A, Miyamoto T, Hokamuro Y, Eguchi N, Hamada T, et al. A CASE OF RHD-NEGATIVE OBSTETRIC CRITICAL HEMORRHAGE SUCCESSFULLY TREATED WITH MASSIVE RHD-POSITIVE BLOOD TRANSFUSION, FOLLOWED BY ANTI-D ANTIBODY PRODUCTION AND DELAYED HEMOLYTIC TRANSFUSION REACTION. Japanese Journal of Transfusion and Cell Therapy. 2026;72(3):610-615. doi:10.3925/jjtc.72.610

BibTeX
@article{Kasabata2026,
  author = {Kasabata, Mio and Mochihara, Ai and Miyamoto, Tamaka and Hokamuro, Yoshihide and Eguchi, Natsuki and Hamada, Tomonori and Tazaki, Yukiko and Kobayashi, Hiroaki and Nakamura, Tatsuro and Hamada, Heiichiro and Furukawa, Yoshitaka},
  title = {A CASE OF RHD-NEGATIVE OBSTETRIC CRITICAL HEMORRHAGE SUCCESSFULLY TREATED WITH MASSIVE RHD-POSITIVE BLOOD TRANSFUSION, FOLLOWED BY ANTI-D ANTIBODY PRODUCTION AND DELAYED HEMOLYTIC TRANSFUSION REACTION},
  journal = {Japanese Journal of Transfusion and Cell Therapy},
  year = {2026},
  volume = {72},
  number = {3},
  pages = {610--615},
  doi = {10.3925/jjtc.72.610}
}
Kostenlos starten →